Acriflavine binds directly to HIF1A and HIF2A domains and is an effective inhibitor of dimerization; treatment with acriflavine effectively reduces tumor growth and angiogenesis in prostate and hepatocyte xenograft models [175]. This evidence concerns the gene HIF1A and neoplasm.